{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T16:37:56Z","timestamp":1765039076988},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2009,1,3]],"date-time":"2009-01-03T00:00:00Z","timestamp":1230940800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2009,7]]},"DOI":"10.1007\/s10552-008-9286-7","type":"journal-article","created":{"date-parts":[[2009,1,5]],"date-time":"2009-01-05T21:38:34Z","timestamp":1231191514000},"page":"731-740","source":"Crossref","is-referenced-by-count":34,"title":["Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: A Danish cohort study"],"prefix":"10.1007","volume":"20","author":[{"given":"S\u00f8ren","family":"Friis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aslak H.","family":"Poulsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik Toft","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Tj\u00f8nneland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Overvad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulla","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph K.","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Blot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00f8rgen H.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,3]]},"reference":[{"key":"9286_CR1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nrc1801","volume":"6","author":"CM Ulrich","year":"2006","unstructured":"Ulrich CM, Bigler J, Potter JD (2006) Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer 6:130\u2013140. doi: 10.1038\/nrc1801","journal-title":"Nat Rev Cancer"},{"key":"9286_CR2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-146-5-200703060-00009","volume":"146","author":"C Dube","year":"2007","unstructured":"Dube C, Rostom A, Lewin G et al (2007) The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 146:365\u2013375","journal-title":"Ann Intern Med"},{"key":"9286_CR3","doi-asserted-by":"crossref","first-page":"376","DOI":"10.7326\/0003-4819-146-5-200703060-00010","volume":"146","author":"A Rostom","year":"2007","unstructured":"Rostom A, Dube C, Lewin G et al (2007) Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med 146:376\u2013389","journal-title":"Ann Intern Med"},{"key":"9286_CR4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.7326\/0003-4819-146-5-200703060-00008","volume":"146","author":"U.S. Preventive Services Task Force","year":"2007","unstructured":"U.S. Preventive Services Task Force (2007) Routine aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 146:361\u2013364","journal-title":"Ann Intern Med"},{"key":"9286_CR5","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","volume":"348","author":"JA Baron","year":"2003","unstructured":"Baron JA, Cole BF, Sandler RS et al (2003) A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 348:891\u2013899. doi: 10.1056\/NEJMoa021735","journal-title":"N Engl J Med"},{"key":"9286_CR6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa021633","volume":"348","author":"RS Sandler","year":"2003","unstructured":"Sandler RS, Halabi S, Baron JA et al (2003) A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 348:883\u2013890. doi: 10.1056\/NEJMoa021633","journal-title":"N Engl J Med"},{"key":"9286_CR7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0016-5085(03)00887-4","volume":"125","author":"R Benamouzig","year":"2003","unstructured":"Benamouzig R, Deyra J, Martin A et al (2003) Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial. Gastroenterology 125:328\u2013336. doi: 10.1016\/S0016-5085(03)00887-4","journal-title":"Gastroenterology"},{"key":"9286_CR8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/j.gastro.2007.10.014","volume":"134","author":"RF Logan","year":"2008","unstructured":"Logan RF, Grainge MJ, Shepherd VC, Armitage NC, Muir KR (2008) Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology 134:29\u201338. doi: 10.1053\/j.gastro.2007.10.014","journal-title":"Gastroenterology"},{"key":"9286_CR9","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJM199305063281805","volume":"328","author":"FM Giardiello","year":"1993","unstructured":"Giardiello FM, Hamilton SR, Krush AJ et al (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328:1313\u20131316. doi: 10.1056\/NEJM199305063281805","journal-title":"N Engl J Med"},{"key":"9286_CR10","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMoa061652","volume":"355","author":"N Arber","year":"2006","unstructured":"Arber N, Eagle CJ, Spicak J et al (2006) Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med 355:885\u2013895. doi: 10.1056\/NEJMoa061652","journal-title":"N Engl J Med"},{"key":"9286_CR11","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJMoa061355","volume":"355","author":"MM Bertagnolli","year":"2006","unstructured":"Bertagnolli MM, Eagle CJ, Zauber AG et al (2006) Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med 355:873\u2013884. doi: 10.1056\/NEJMoa061355","journal-title":"N Engl J Med"},{"key":"9286_CR12","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1053\/j.gastro.2006.08.079","volume":"131","author":"JA Baron","year":"2006","unstructured":"Baron JA, Sandler RS, Bresalier RS et al (2006) A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology 131:1674\u20131682. doi: 10.1053\/j.gastro.2006.08.079","journal-title":"Gastroenterology"},{"key":"9286_CR13","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/jnci\/85.15.1220","volume":"85","author":"PH Gann","year":"1993","unstructured":"Gann PH, Manson JE, Glynn RJ, Buring JE, Hennekens CH (1993) Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst 85:1220\u20131224. doi: 10.1093\/jnci\/85.15.1220","journal-title":"J Natl Cancer Inst"},{"key":"9286_CR14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/jama.294.1.47","volume":"294","author":"NR Cook","year":"2005","unstructured":"Cook NR, Lee IM, Gaziano JM et al (2005) Low-dose aspirin in the primary prevention of cancer: the Women\u2019s Health Study: a randomized controlled trial. JAMA 294:47\u201355. doi: 10.1001\/jama.294.1.47","journal-title":"JAMA"},{"key":"9286_CR15","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(07)60747-8","volume":"369","author":"E Flossmann","year":"2007","unstructured":"Flossmann E, Rothwell PM (2007) Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 369:1603\u20131613. doi: 10.1016\/S0140-6736(07)60747-8","journal-title":"Lancet"},{"key":"9286_CR16","first-page":"1322","volume":"53","author":"MJ Thun","year":"1993","unstructured":"Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW Jr (1993) Aspirin use and risk of fatal cancer. Cancer Res 53:1322\u20131327","journal-title":"Cancer Res"},{"key":"9286_CR17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/sj.bjc.6690651","volume":"81","author":"JP Collet","year":"1999","unstructured":"Collet JP, Sharpe C, Belzile E, Boivin JF, Hanley J, Abenhaim L (1999) Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing. Br J Cancer 81:62\u201368. doi: 10.1038\/sj.bjc.6690651","journal-title":"Br J Cancer"},{"key":"9286_CR18","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.294.8.914","volume":"294","author":"AT Chan","year":"2005","unstructured":"Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS (2005) Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer. JAMA 294:914\u2013923. doi: 10.1001\/jama.294.8.914","journal-title":"JAMA"},{"key":"9286_CR19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/aje\/kwj250","volume":"164","author":"M Allison","year":"2006","unstructured":"Allison M, Garland C, Chlebowski R et al (2006) The association between aspirin use and the incidence of colorectal cancer in women. Am J Epidemiol 164:567\u2013575. doi: 10.1093\/aje\/kwj250","journal-title":"Am J Epidemiol"},{"key":"9286_CR20","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/sj.bjc.6603442","volume":"95","author":"SC Larsson","year":"2006","unstructured":"Larsson SC, Giovannucci E, Wolk A (2006) Long-term aspirin use and colorectal cancer risk: a cohort study in Sweden. Br J Cancer 95:1277\u20131279. doi: 10.1038\/sj.bjc.6603442","journal-title":"Br J Cancer"},{"key":"9286_CR21","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/jnci\/djk132","volume":"99","author":"EJ Jacobs","year":"2007","unstructured":"Jacobs EJ, Thun MJ, Bain EB, Rodriguez C, Henley SJ, Calle EE (2007) A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. J Natl Cancer Inst 99:608\u2013615. doi: 10.1093\/jnci\/djk132","journal-title":"J Natl Cancer Inst"},{"key":"9286_CR22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/j.gastro.2007.09.035","volume":"134","author":"AT Chan","year":"2008","unstructured":"Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Wu K, Fuchs CS (2008) Aspirin dose and duration of use and risk of colorectal cancer in men. Gastroenterology 134:21\u201328. doi: 10.1053\/j.gastro.2007.09.035","journal-title":"Gastroenterology"},{"key":"9286_CR23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/jnci\/83.5.355","volume":"83","author":"L Rosenberg","year":"1991","unstructured":"Rosenberg L, Palmer JR, Zauber AG, Warshauer ME, Stolley PD, Shapiro S (1991) A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst 83:355\u2013358. doi: 10.1093\/jnci\/83.5.355","journal-title":"J Natl Cancer Inst"},{"key":"9286_CR24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archinte.159.2.161","volume":"159","author":"W Smalley","year":"1999","unstructured":"Smalley W, Ray WA, Daugherty J, Griffin MR (1999) Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study. Arch Intern Med 159:161\u2013166. doi: 10.1001\/archinte.159.2.161","journal-title":"Arch Intern Med"},{"key":"9286_CR25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00001648-200101000-00015","volume":"12","author":"LA Garcia-Rodriguez","year":"2001","unstructured":"Garcia-Rodriguez LA, Huerta-Alvarez C (2001) Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs. Epidemiology 12:88\u201393. doi: 10.1097\/00001648-200101000-00015","journal-title":"Epidemiology"},{"key":"9286_CR26","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/aje\/kwi248","volume":"162","author":"LB Sansbury","year":"2005","unstructured":"Sansbury LB, Millikan RC, Schroeder JC, Moorman PG, North KE, Sandler RS (2005) Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case-control study of African Americans and Whites. Am J Epidemiol 162:548\u2013558. doi: 10.1093\/aje\/kwi248","journal-title":"Am J Epidemiol"},{"key":"9286_CR27","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s10552-006-0075-x","volume":"17","author":"S Kim","year":"2006","unstructured":"Kim S, Baron JA, Mott LA et al (2006) Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States). Cancer Causes Control 17:1299\u20131304. doi: 10.1007\/s10552-006-0075-x","journal-title":"Cancer Causes Control"},{"key":"9286_CR28","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0016-5085(99)70342-2","volume":"117","author":"B Agarwal","year":"1999","unstructured":"Agarwal B, Rao CV, Bhendwal S et al (1999) Lovastatin augments sulindac-induced apoptosis in colon cancer cells and potentiates chemopreventive effects of sulindac. Gastroenterology 117:838\u2013847. doi: 10.1016\/S0016-5085(99)70342-2","journal-title":"Gastroenterology"},{"key":"9286_CR29","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1158\/0008-5472.CAN-05-4428","volume":"66","author":"BS Reddy","year":"2006","unstructured":"Reddy BS, Wang CX, Kong AN et al (2006) Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats. Cancer Res 66:4542\u20134546. doi: 10.1158\/0008-5472.CAN-05-4428","journal-title":"Cancer Res"},{"key":"9286_CR30","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/ijc.22796","volume":"121","author":"M Hoffmeister","year":"2007","unstructured":"Hoffmeister M, Chang-Claude J, Brenner H (2007) Individual and joint use of statins and low-dose aspirin and risk of colorectal cancer: a population-based case-control study. Int J Cancer 121:1325\u20131330. doi: 10.1002\/ijc.22796","journal-title":"Int J Cancer"},{"key":"9286_CR31","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/ijc.23718","volume":"123","author":"H Xiao","year":"2008","unstructured":"Xiao H, Yang CS (2008) Combination regimen with statins and NSAIDs: a promising strategy for cancer chemoprevention. Int J Cancer 123:983\u2013990. doi: 10.1002\/ijc.23718","journal-title":"Int J Cancer"},{"key":"9286_CR32","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1200\/JCO.2007.10.8936","volume":"25","author":"S Bonovas","year":"2007","unstructured":"Bonovas S, Filioussi K, Flordellis CS, Sitaras NM (2007) Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients. J Clin Oncol 25:3462\u20133468. doi: 10.1200\/JCO.2007.10.8936","journal-title":"J Clin Oncol"},{"key":"9286_CR33","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1200\/JCO.2005.08.097","volume":"23","author":"ET Hawk","year":"2005","unstructured":"Hawk ET, Levin B (2005) Colorectal cancer prevention. J Clin Oncol 23:378\u2013391. doi: 10.1200\/JCO.2005.08.097","journal-title":"J Clin Oncol"},{"key":"9286_CR34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2036.2007.03380.x","volume":"26","author":"AW DuPont","year":"2007","unstructured":"DuPont AW, Arguedas MR, Wilcox CM (2007) Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis. Aliment Pharmacol Ther 26:431\u2013441","journal-title":"Aliment Pharmacol Ther"},{"key":"9286_CR35","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1080\/14034940601047986","volume":"35","author":"A Tj\u00f8nneland","year":"2007","unstructured":"Tj\u00f8nneland A, Olsen A, Boll K et al (2007) Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 35:432\u2013441. doi: 10.1080\/14034940601047986","journal-title":"Scand J Public Health"},{"key":"9286_CR36","first-page":"263","volume":"46","author":"TF Andersen","year":"1999","unstructured":"Andersen TF, Madsen M, J\u00f8rgensen J, Mellemkj\u00e6r L, Olsen JH (1999) The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46:263\u2013268","journal-title":"Dan Med Bull"},{"key":"9286_CR37","first-page":"445","volume":"44","author":"D Gaist","year":"1997","unstructured":"Gaist D, S\u00f8rensen HT, Hallas J (1997) The Danish prescription registries. Dan Med Bull 44:445\u2013448","journal-title":"Dan Med Bull"},{"key":"9286_CR38","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1126\/science.287.5462.2398","volume":"287","author":"L Frank","year":"2000","unstructured":"Frank L (2000) Epidemiology. When an entire country is a cohort. Science 287:2398\u20132399. doi: 10.1126\/science.287.5462.2398","journal-title":"Science"},{"key":"9286_CR39","volume-title":"Guidelines for ATC classification and DDD assignments","author":"World Health Organization Collaborating Centre for Drug Statistics Methodology","year":"2001","unstructured":"World Health Organization Collaborating Centre for Drug Statistics Methodology (2001) Guidelines for ATC classification and DDD assignments. World Health Organization Collaborating Centre for Drug Statistics Methodology, Oslo"},{"key":"9286_CR40","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/sj.bjc.6600945","volume":"88","author":"HT S\u00f8rensen","year":"2003","unstructured":"S\u00f8rensen HT, Friis S, N\u00f8rg\u00e5rd B et al (2003) Risk of cancer in a large cohort of nonaspirin NSAID users: a population-based study. Br J Cancer 88:1687\u20131692. doi: 10.1038\/sj.bjc.6600945","journal-title":"Br J Cancer"},{"key":"9286_CR41","volume-title":"Danish Classification of Surgical Procedures and Therapies","author":"Danish Board of Health","year":"1995","unstructured":"Danish Board of Health (1995) Danish Classification of Surgical Procedures and Therapies. Danish Board of Health, Copenhagen"},{"key":"9286_CR42","first-page":"535","volume":"44","author":"HH Storm","year":"1997","unstructured":"Storm HH, Michelsen EV, Clemmensen IH, Pihl J (1997) The Danish Cancer Registry\u2014history, content, quality and use. Dan Med Bull 44:535\u2013539","journal-title":"Dan Med Bull"},{"key":"9286_CR43","first-page":"1401","volume":"167","author":"M Vyberg","year":"2005","unstructured":"Vyberg M, Bjerregaard B, Bak M, Gram I, Hvolris H (2005) Pathology database. Danish Society of Pathologic Anatomy and Cytology. Ugeskr Laeger 167:1401","journal-title":"Ugeskr Laeger"},{"key":"9286_CR44","volume-title":"Cancer incidence in Denmark, 2001","author":"National Board of Health","year":"2006","unstructured":"National Board of Health (2006) Cancer incidence in Denmark, 2001. National Board of Health, Copenhagen, Denmark"},{"key":"9286_CR45","unstructured":"Engholm G, Storm HH, Ferlay J et\u00a0al. (2008) NORDCAN: cancer incidence, mortality and prevalence in the Nordic Countries. Association of Nordic Cancer Registries. Danish Cancer Society, Copenhagen"},{"key":"9286_CR46","volume-title":"Obesity: preventing and managing the global epidemic. WHO Technical Report Series No 894","author":"World Health Organization","year":"2000","unstructured":"World Health Organization (2000) Obesity: preventing and managing the global epidemic. WHO Technical Report Series No 894. World Health Organization, Geneva"},{"key":"9286_CR47","volume-title":"Medicinal Product Statistics in Denmark 2003\u20132007","author":"Danish Medicines Agency","year":"2008","unstructured":"Danish Medicines Agency (2008) Medicinal Product Statistics in Denmark 2003\u20132007. Danish Medicines Agency, Copenhagen"},{"key":"9286_CR48","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1053\/j.gastro.2007.05.023","volume":"133","author":"Y Vinogradova","year":"2007","unstructured":"Vinogradova Y, Hippisley-Cox J, Coupland C, Logan RF (2007) Risk of colorectal cancer in patients prescribed statins, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 inhibitors: nested case-control study. Gastroenterology 133:393\u2013402. doi: 10.1053\/j.gastro.2007.05.023","journal-title":"Gastroenterology"},{"key":"9286_CR49","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.bjc.6600760","volume":"88","author":"S Friis","year":"2003","unstructured":"Friis S, S\u00f8rensen HT, McLaughlin JK, Johnsen SP, Blot WJ, Olsen JH (2003) A population-based cohort study of the risk of colorectal and other cancers among users of low-dose aspirin. Br J Cancer 88:684\u2013688. doi: 10.1038\/sj.bjc.6600760","journal-title":"Br J Cancer"},{"key":"9286_CR50","volume-title":"Food, nutrition, physical activity, and the prevention of cancer: a global perspective","author":"World Cancer Research Fund\/American Institute for Cancer Research","year":"2007","unstructured":"World Cancer Research Fund\/American Institute for Cancer Research (2007) Food, nutrition, physical activity, and the prevention of cancer: a global perspective. AICR, Washington DC"},{"key":"9286_CR51","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1017\/S0029665108006976","volume":"67","author":"T Pischon","year":"2008","unstructured":"Pischon T, Nothlings U, Boeing H (2008) Obesity and cancer. Proc Nutr Soc 67:128\u2013145. doi: 10.1017\/S0029665108006976","journal-title":"Proc Nutr Soc"},{"key":"9286_CR52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jnutbio.2005.06.011","volume":"17","author":"MJ Gunter","year":"2006","unstructured":"Gunter MJ, Leitzmann MF (2006) Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. J Nutr Biochem 17:145\u2013156. doi: 10.1016\/j.jnutbio.2005.06.011","journal-title":"J Nutr Biochem"},{"key":"9286_CR53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/35094017","volume":"1","author":"RA Gupta","year":"2001","unstructured":"Gupta RA, DuBois RN (2001) Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2. Nat Rev Cancer 1:11\u201321","journal-title":"Nat Rev Cancer"},{"key":"9286_CR54","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0165-6147(02)00043-3","volume":"24","author":"K Subbaramaiah","year":"2003","unstructured":"Subbaramaiah K, Dannenberg AJ (2003) Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol Sci 24:96\u2013102. doi: 10.1016\/S0165-6147(02)00043-3","journal-title":"Trends Pharmacol Sci"},{"key":"9286_CR55","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1158\/1055-9965.538.13.4","volume":"13","author":"ML Slattery","year":"2004","unstructured":"Slattery ML, Samowitz W, Hoffman M, Ma KN, Levin TR, Neuhausen S (2004) Aspirin, NSAIDs, and colorectal cancer: possible involvement in an insulin-related pathway. Cancer Epidemiol Biomarkers Prev 13:538\u2013545","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"9286_CR56","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/sj.bjc.6604151","volume":"98","author":"JH Olsen","year":"2008","unstructured":"Olsen JH, Friis S, Poulsen AH et al (2008) Use of NSAIDs, smoking and lung cancer risk. Br J Cancer 98:232\u2013237. doi: 10.1038\/sj.bjc.6604151","journal-title":"Br J Cancer"}],"container-title":["Cancer Causes & Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-008-9286-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-008-9286-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-008-9286-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T10:56:26Z","timestamp":1684839386000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-008-9286-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,3]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,7]]}},"alternative-id":["9286"],"URL":"https:\/\/doi.org\/10.1007\/s10552-008-9286-7","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"value":"0957-5243","type":"print"},{"value":"1573-7225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,3]]}}}